CEO resigns effective Dec 1, 2026
Travere Therapeutics, Inc. announced the resignation of CEO Eric Dube effective December 1, 2026. This executive change underscores potential strategic shifts within the leadership structure of the biopharmaceutical company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed